Neurocysticercosis treated with praziquantel. Long-term follow-up of a case
Related Experiment Video
Updated: Oct 23, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
P Mancuso1, I Chiaramonte, R Tropea
1Cattedra di Neurochirurgia, Università degli Studi di Catania, Italy.
Abstract:
The Authors report a case of neurocysticercosis treated with praziquantel and ventriculoperitoneal shunt. The patient presented, at CAT, multiple intracranial calcifications and cysts located in the cerebral parenchyma, ventricular system and subarachnoid cisterns. Praziquantel was orally administered at a daily dosage of 50 mg/kg. Two 15 day cycles of therapy were administered with an interval of one month between them. No significant side effects were observed during the treatment. Serial follow-up CAT scans demonstrated a gradual decrease in size and, finally, total disappearance of the cystic lesions. No neurological disfunction was observed at the last follow-up examination 4 years after treatment.
Related Concept Videos
Rocky Mountain Spotted Fever
Toxoplasmosis
American Trypanosomiasis
Anthelminthic Agents
Antiprotozoal Agents

